These proteins have been previously implicated in endothelial dysfunction or atherosclerosis (36, 37), with raised circulating levels of NGAL associated with cardiovascular events and with hypoxemia in COPD (38, 39). This evidence concerns the gene LCN2 and atherosclerosis.